Chief Scientific Officer
Dr. Tsukerman received his Ph.D. from the Hebrew University at the lab of Prof. Mandelboim. During his Ph.D., Dr. Tsukerman authored over 20 publications and numerous patents. Dr. Tsukerman is an expert in the field of cellular and molecular immunology with vast experience in generation of novel therapeutic agents, such as monoclonal antibodies and fusion proteins for treatment of cancer. Dr. Tsukerman is the recipient of numerous excellence awards including Bester award for cancer research and Kaye innovation award.